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Introduction There is an association between congenital heart
disease (CHD) and neurodevelopmental delay (42%). Brain injury
can be minimized by adequate perfusion control based on NIRS (6%
Vs 26%): a low NIRS index under 40% is a good predictor of brain
lesion. Here, monitoring must be foolproof and easy to understand.
Assessed parameters must imply the opportunity of an early inter-
vention by the physician. Alas, NIRS is assessed peri-operatively.
Our aim was to ﬁnd an earlier predictor that could be used to assess
brain vulnerability pre-operatively.
Methods We prospectively enrolled 14 children (mean± SD:
age = 2.2± 3.3 y.o.; weight = 9.4± 9 Kg) who underwent cardiopul-
monary bypass for a CHD repair surgery. Cerebral oxygen saturation
(rSo2) was monitored by NIRS. We calculated the NIRS as de dif-
ference between NIRS level before the procedure and during the
CPB. We compared the rSO2 data with the physiologic brain status
assessed by a computed electroencephalogram (EEG spectral anal-
ysis). This later provided four spectral index (alpha, beta, delta,
theta).
Results The NIRS decreased during CPB. NIRS value was 24,21%
(± 16.28) .Two patients had a NIRS impairment below 40% (14.3%).
There was no correlation between NIRS and either the spectral index
alpha, delta or theta. Linear regression based on Beta index shows
two signiﬁcant relationships. The preoperative beta spectral index
is correlated with the NIRS (P = 0,03*1) and with the minimum NIRS
level during the CPB (P = 0.01).
Conclusion Preoperative Beta spectral index is therefore an early
predictor of brain vulnerability. A high Beta index preoperatively
could predict a low NIRS index during CPB and therefore a possibility
of brain injury. That was a preliminary study and our ﬁndings need to
be validated onto a wider panel of patients. Beta index is probably
could be linked to the CHD type too. Nevertheless, beta index could
help to design targeted procedure for brain protection adapted to
each type of patient.
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Objectives Life expectancy of patients with Marfan syndrome
has increased, due to earlier diagnosis, better familial screening,
regular follow-up (FU) and prophylactic aortic surgery (PASu). Inci-
dence of events in affected patients recognized during childhood is
unknown.
Methods Four hundred and sixty-ﬁve patients with Marfan syn-
drome, diagnosed before 18 years old were included in the French
multicenter database. Cardio-vascular events (death, aortic dissec-
tion or PASu) were recorded.
Results A cardio-vascular event occurred in 25 patients (5.4%
95CI 3.5—7.8%), including PASu (n = 20, 4.3% 95CI 2.5—6.2%), aor-
tic dissection (n = 3, 0.6% 95CI 0.0—1.4%) and deaths (n = 2, 0.4%
95CI 0.0—1.0%) (Appendix A). Sixteen events (64%) occurred before
19 years old (Median 15.0, min. 2.8, interquartile 11.7—16.3; PASu
n = 12, deaths n = 2 and dissection n = 2). An aortic surgery was per-
formed in 23 patients (4.9%, 95CI 3.0—6.9%), including a Bentall
procedure with mechanical aortic valve in 10 (43.5%), a valve spar-
ing surgery in the remaining 13 (56.5%) and a supra-coronary graft
in 4 (17.4%, dissection: n = 2 and PASu: n = 2). Mean age at the date
of PASu was 17.1± 6.5 year-old. Events occurred before or at inclu-
sion in the database in 8 patients (32.0%) (PASu n = 5, dissection n = 2,
death n = 1). Dissection was observed before inclusion in 2 patients
and during pregnancy in 1 patient. Kaplan-Meier survival estimate
indicates that 95% of patients remained free from events at eighteen
and 78% at thirty years old.
Conclusion Prophylactic surgery for enlarged aorta is the main
cause of cardiac events in patients with Marfan syndrome diagnosed
during childhood. A quarter of them have a cardiac event before
thirty years old.
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Background Congenital heart disease (CHD) are seldom cured and
the increasing grown-up congenital heart disease (GUCH) popula-
tion still needs specialized follow-up that has to be organized. In
Reims University Hospital, it’s about 10 years ago that pediatric and
adult cardiologists initiated a multidisciplinary clinic for follow-up
of GUCH patients.
Objectives The aim of the present study is to describe the GUCH
population followed in our hospital (CHD, treatments, outcomes,
complications, social issues) and the organization of their medical
care.
Methods This is a retrospective and observational study including
patients with CHD which were over 18 years old in September 2013
and were seen in Reims University Hospital at least once between
January 2008 and September 2013.
Results Our GUCH population was 475 patients. Median age was
25.1 years old. Sex ratio was 0.82. Among CHD, univentricular
hearts were 10%. Thirty-one percent of patients were taking cardi-
ologic medications. Cardiac surgery had been performed in 62.1%.
Interventional catheterization had been undertaken in 19.6%.
Regarding the outcome, main complications were arrhythmias
(17%), heart failure (5%), pulmonary hypertension (4%), endocardi-
tis (1.2%), death (1.9%). Social supervision was needed in 14.3%.
Twenty-six percent of patients had a life partner and 12.4% had
children. During the period study, 11.7% of patients were lost to
follow-up.
Conclusions After reaching adulthood, patients with CHD need
continuous follow-up because complications in GUCH patients are
not uncommon. Although transition between adolescence and adult-
hood is supposed to be at high risk of breaking this follow-up, the
present study shows that it is possible to minimize this event. We
feel that an organized continuum of care between pediatric and
adults cardiologists, as we settled in our hospital, could be an effec-
tive way to meet the special needs of GUCH patients.
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Summary In the context of recent change in guidelines for pro-
phylaxis of infective endocarditis (IE), the objective of this study
was to assess the features and outcomes of IE in children and adults
with non-signiﬁcant ventricular septal defect (VSD).
Methods A retrospective analysis of records of patients with
non-signiﬁcant VSD. Clinical, echocardiographic and microbiological
data, and outcomes were assessed.
Results From 1980 to 2013, 57 IE occurred (1 to 4 per year), in
patients aged 14.2± 11.3 years (med. 12.1), 29males (51%) and
39 were < 18 years of age. VSD was membranous in all cases, iso-
lated (39 = 68.5%) or associated with mild aortic regurgitation or
pulmonary stenosis. VSD was native in 39 (68.5%) and not diag-
nosed before IE occurred in 4cases (7%). The cause of infection was
unknown in 36% of the cases, while 23% were from dental, 13% from
cutaneous, 9% from ENT or digestive origin, and 19% occurred in the
early postoperative course of patch closure, i.e. 81% of the cases
occurred in native mild VSD. Streptococcus from dental origin was
the most frequent causal agent (54.5%), staphylococcus was found
in 35% of cases, Gram-negative bacillus in 3.5%. Hemocultures were
negative in 7% of the cases. Vegetation was the most frequent echo-
graphic lesion, and located either on VSD, and/or tricuspid valve
and/or RV free wall and/or pulmonary valve. Aortic valve location
occurred in 8cases. Embolic event occurred in 28 cases (49%): multi-
ple pulmonary embolia in 21 (37%), systemic embolia in 6. Eighteen
patients were operated (31.6%): early surgery in 11 (19.3%), delayed
patch closure in 7. Six patients died (10.5%). Death was not related
to early surgery. FU was 13.4± 11.2 years (med. 10.2 years).
Conclusion Infective endocarditis impairs prognosis of mild mem-
branous VSD and dental events are the most frequent origin of
infection. Preventive surveillance and management of any dental
lesion are probably to be emphasized in these patients.
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The pathophysiology of ventricular septal defect (VSD) is deter-
mined by the size of the defect and the state of the pulmonary
